Freebies to MDs targeted as drug industry starts publicizing CME fines
Patrick Sullivan
Abstract
Patrick Sullivan
Abstract
Canada‚s drug companies are now getting their knuckles rapped publicly if they violate industry rules concerning the CME events they sponsor. Several rulings made by the Marketing Practices Review Committee of Canada‚s Research-Based Pharmaceutical Companies (Rx&D, formerly the Pharmaceutical
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Canada‚s drug companies are now getting their knuckles rapped publicly if they violate industry rules concerning the CME events they sponsor. Several rulings made by the Marketing Practices Review Committee of Canada‚s Research-Based Pharmaceutical Companies (Rx&D, formerly the Pharmaceutical
Key concepts: Drug industry, Pharmaceutical industry, Drug approval, Business, Drug, Medicine, Pharmacology, Engineering